Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP2883741B2 - Dental cement hardener - Google Patents
[go: Go Back, main page]

JP2883741B2 - Dental cement hardener - Google Patents

Dental cement hardener

Info

Publication number
JP2883741B2
JP2883741B2 JP2401034A JP40103490A JP2883741B2 JP 2883741 B2 JP2883741 B2 JP 2883741B2 JP 2401034 A JP2401034 A JP 2401034A JP 40103490 A JP40103490 A JP 40103490A JP 2883741 B2 JP2883741 B2 JP 2883741B2
Authority
JP
Japan
Prior art keywords
powder
polymer
parts
cement
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2401034A
Other languages
Japanese (ja)
Other versions
JPH0624927A (en
Inventor
二平 猪俣
裕也 丸山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dai Nippon Toryo Co Ltd
Original Assignee
Dai Nippon Toryo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dai Nippon Toryo Co Ltd filed Critical Dai Nippon Toryo Co Ltd
Priority to JP2401034A priority Critical patent/JP2883741B2/en
Publication of JPH0624927A publication Critical patent/JPH0624927A/en
Application granted granted Critical
Publication of JP2883741B2 publication Critical patent/JP2883741B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Compositions Of Macromolecular Compounds (AREA)
  • Polymerisation Methods In General (AREA)
  • Dental Preparations (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、歯科用セメント粉末か
らなる粉末成分と混合する際の操作性、練和性等に優
れ、かつ破砕抗力等の物理的強度に優れたセメント硬化
物が得られる歯科用セメント硬化剤に関する。
BACKGROUND OF THE INVENTION The present invention provides a hardened cement material which is excellent in operability and kneadability when mixed with a powder component comprising a dental cement powder, and which is excellent in physical strength such as crush resistance. Dental cement hardener.

【0002】[0002]

【従来の技術及びその解決すべき課題】歯科セメント組
成物は歯の修復用充填材、インレー又は歯冠の接合材、
矯正歯の接合材、裏層材等に広く適用されている。歯科
セメント組成物は、通常歯科用セメント粉末、さらに必
要に応じX線造影剤粉末、充填剤粉末(増量剤)からな
る粉末成分とセメント硬化剤水溶液とから構成されてい
る。
BACKGROUND OF THE INVENTION Dental cement compositions are used as dental restorative fillers, inlay or crown cements,
Widely used for bonding materials and backing materials for orthodontic teeth. The dental cement composition is usually composed of a dental cement powder, and further, if necessary, a powder component comprising an X-ray contrast agent powder and a filler powder (extending agent), and an aqueous cement hardener solution.

【0003】これら歯科セメント組成物は、乾燥粉末形
態の前記粉末成分を使用直前にセメント硬化剤水溶液と
混合、練和し、該練和物を患部に充填し、セメント硬化
物を形成するものである。
[0003] These dental cement compositions are prepared by mixing and kneading the powder component in a dry powder form with an aqueous solution of a cement hardener immediately before use, filling the kneaded material into an affected area to form a hardened cement material. is there.

【0004】前記セメント硬化剤水溶液としては、線状
のアクリル酸重合体もしくはアクリル酸と、他の共重合
性不飽和モノマーとの共重合体の水溶液が最も広く利用
されている。このセメント硬化剤水溶液の、それぞれの
利点、問題点は既に明らかになっているが、共通した大
きな問題点としては前記粉末成分との練和性が十分でな
い点にある。
[0004] As the aqueous cement hardener solution, an aqueous solution of a linear acrylic acid polymer or a copolymer of acrylic acid and another copolymerizable unsaturated monomer is most widely used. Although the advantages and problems of the aqueous cement hardener solution have already been clarified, a common major problem is that the kneadability with the powder component is not sufficient.

【0005】通常、セメント粉末からなる粉末成分と硬
化剤水溶液とは、練和板(又は練和紙)上で一定比率で
混合、練和し、硬化反応が実質的に進まないうちに、即
ち、流動性の大きい状態のうちに、患部に適用しなけれ
ばならず、それ故前記練和の操作は極力短時間に完了し
なければならない。また、練和を短時間で、かつ十分に
行なわないと歯科セメント組成物本来の性能が発揮され
ず、その結果セメント硬化物の最終性能にバラツキが生
じやすくなる。
[0005] Usually, a powder component composed of cement powder and a hardener aqueous solution are mixed and kneaded at a fixed ratio on a kneading plate (or kneaded paper), and before the hardening reaction substantially proceeds, that is, It must be applied to the affected area while the fluidity is high, so that the kneading operation must be completed in a short time. In addition, if the kneading is not performed sufficiently in a short time, the original performance of the dental cement composition is not exhibited, and as a result, the final performance of the hardened cement material tends to vary.

【0006】ところが、本来水となじみにくい前記粉末
成分を硬化剤水溶液と短時間で均一に混合するだけでも
困難を伴い、更にヘラ等で練和することは容易でなく、
練和に高度の熟練が必要であった。本発明者等はこのよ
うな現状に鑑み、鋭意研究した結果、前記粉末成分との
練和性等に優れ、かつ物理的強度に優れたセメント硬化
物が得られる硬化剤を見出し、本発明に到達したもので
ある。
However, it is difficult to mix the above-mentioned powder component, which is inherently incompatible with water, uniformly with the aqueous solution of the curing agent in a short time, and it is not easy to knead with a spatula or the like.
The training required a high degree of skill. In view of such circumstances, the present inventors have conducted intensive studies and as a result, have found a hardening agent which is excellent in kneadability with the powder component and the like, and which can obtain a cement hardened material having excellent physical strength, and the present invention. It has been reached.

【0007】[0007]

【課題を解決するための手段】即ち、本発明は、水系媒
体中で、X線造影剤粉末、及び/又は、充填剤粉末存在
下に不飽和カルボン酸モノマーもしくは該モノマーと、
他の共重合性不飽和モノマーとの混合モノマーを重合さ
せて得られる重合体−X線造影剤複合体、もしくは重合
体−充填剤複合体からなる歯科用セメント硬化剤に関す
る。
That is, the present invention relates to an unsaturated carboxylic acid monomer or a monomer thereof in an aqueous medium in the presence of an X-ray contrast agent powder and / or a filler powder.
The present invention relates to a dental cement hardener comprising a polymer-X-ray contrast agent composite or a polymer-filler composite obtained by polymerizing a mixed monomer with another copolymerizable unsaturated monomer.

【0008】以下、本発明について詳細に説明する。Hereinafter, the present invention will be described in detail.

【0009】本発明において使用されるX線造影剤粉末
としては、通常歯科用X線造影剤に使用されている公知
の各種X線造影剤が特に制限なく利用出来る。
As the X-ray contrast agent powder used in the present invention, various known X-ray contrast agents which are usually used for dental X-ray contrast agents can be used without any particular limitation.

【0010】具体的には、例えば硫酸バリウム、次炭酸
ビスマス、酸化ビスマス、銀粉、無水乳酸亜鉛、硫酸ア
ルミニウム、カリウム、酸化チタン等が代表的なものと
して挙げられる。
Specific examples include barium sulfate, bismuth subcarbonate, bismuth oxide, silver powder, anhydrous zinc lactate, aluminum sulfate, potassium, and titanium oxide.

【0011】X線造影剤粉末の粒径は得られる重合体−
X線造影剤複合体の水性懸濁液の分散安定性等の観点か
ら平均粒径50μm以下、好ましくは1〜10μmが適
当である。また本発明において使用される充填剤粉末
は、増量剤として使用されるものであり、実質的に硬化
剤と反応しないものであり、具体的には、酸化マグネシ
ウム、酸化ビスマス、酸化カルシウム、シリカ、アルミ
ナ、氷晶石、リン酸アルミニウム、フッ化アルミニウ
ム、フッ化カルシウム、水酸化カルシウム等が代表的な
ものとして挙げられる。
The particle size of the X-ray contrast agent powder is determined by the polymer obtained.
From the viewpoint of the dispersion stability of the aqueous suspension of the X-ray contrast agent complex, the average particle diameter is suitably 50 μm or less, preferably 1 to 10 μm. The filler powder used in the present invention is used as a bulking agent and does not substantially react with a curing agent.Specifically, magnesium oxide, bismuth oxide, calcium oxide, silica, Typical examples include alumina, cryolite, aluminum phosphate, aluminum fluoride, calcium fluoride, calcium hydroxide and the like.

【0012】充填剤粉末の粒径は得られる重合体−充填
剤複合体の水性懸濁液の分散安定性等の観点から平均粒
径50μm以下、好ましくは0.01〜10μmが適当で
ある。
The average particle size of the filler powder is suitably 50 μm or less, preferably 0.01 to 10 μm, from the viewpoint of the dispersion stability of the aqueous suspension of the obtained polymer-filler complex.

【0013】本発明において使用される、重合体を形成
する構成モノマーである不飽和カルボン酸モノマーとし
てはアクリル酸、メタクリル酸、マレイン酸、フマール
酸、イタコン酸、アコニット酸、グルタコン酸、シコラ
コン酸、メサコン酸、チグール酸等の1種もしくは、こ
れらの2種以上の混合物が代表的なものとして挙げられ
る。
The unsaturated carboxylic acid monomer which is a constituent monomer of the polymer used in the present invention includes acrylic acid, methacrylic acid, maleic acid, fumaric acid, itaconic acid, aconitic acid, glutaconic acid, sicolaconic acid, One of mesaconic acid, tiguric acid and the like, or a mixture of two or more of these, may be mentioned as a typical example.

【0014】他の共重合性不飽和モノマーとしてはアク
リロニトリル、アクリル酸メチル、メタクリル酸メチ
ル、酢酸ビニル、プロピオン酸ビニル、イタコン酸メチ
ル、スチレン、メタクリル酸2−ヒドロキシエチル等の
1種もしくはこれらの2種以上の混合物が代表的なもの
として挙げられる。
The other copolymerizable unsaturated monomer is acrylonitrile, methyl acrylate, methyl methacrylate, vinyl acetate, vinyl propionate, methyl itaconate, styrene, 2-hydroxyethyl methacrylate, or a mixture thereof. Mixtures of more than one species are mentioned as representative.

【0015】なお、得られる重合体の平均分子量は、好
ましくは1,500 〜150,000 程度が適当であり、また重合
体中の不飽和カルボン酸モノマーの構成割合は、好まし
くは90〜100重量%程度が適当であるが、これらに
限定されるものではない。
The average molecular weight of the obtained polymer is preferably about 1,500 to 150,000, and the proportion of unsaturated carboxylic acid monomer in the polymer is preferably about 90 to 100% by weight. However, the present invention is not limited to these.

【0016】本発明において使用される水系媒体として
は水もしくは水を主成分とし、水可溶性アルコール類、
例えばエタノール、イソプロパノール、親水性グリコー
ル、多価アルコール及びその低級アルキルエーテル等を
混合した媒体が代表的なものとして挙げられる。
As the aqueous medium used in the present invention, water or water as a main component, water-soluble alcohols,
For example, a medium in which ethanol, isopropanol, hydrophilic glycol, polyhydric alcohol, a lower alkyl ether thereof and the like are mixed is exemplified.

【0017】次に、本発明の歯科用セメント硬化剤の代
表的な製造方法につき説明するが、無論この方法に限定
されるものではない。
Next, a typical method for producing the dental cement hardener of the present invention will be described, but it is needless to say that the present invention is not limited to this method.

【0018】過硫酸塩、過酸化水素、有機過酸化物ある
いは酸化還元系等の公知の重合開始剤及び必要に応じ分
子量を調整するための連鎖移動剤を含有せしめ、かつX
線造影剤粉末及び/又は、充填剤粉末を分散せしめた水
系媒体中に不飽和カルボン酸モノマーもしくは該モノマ
ーと他の共重合性不飽和モノマーを滴下し、ラジカル重
合せしめる。なお、重合条件は特に制限されないが、一
般的には常圧下で50〜100℃の条件下で重合させる
のが適当である。また、X線造影剤粉末及び/又は、充
填剤粉末と前記モノマーとの割合は実質的に重合を妨げ
るような物理的、化学的条件を除けば特に制限はない
が、得られる重合体−X線造影剤複合体、もしくは重合
体−充填剤複合体の水性懸濁液の安定性、硬化剤として
の本来の機能を考慮した場合、重量比率で(0.1 〜1
0):(99.9〜90)程度が適当である。しかしなが
ら歯科用セメント粉末や前記モノマーの種類等により反
応性が異なるため適宜、好適割合を選択することが出来
る。
A known polymerization initiator such as a persulfate, hydrogen peroxide, an organic peroxide or an oxidation-reduction system, and a chain transfer agent for adjusting the molecular weight, if necessary, are added.
An unsaturated carboxylic acid monomer or another monomer copolymerizable with the unsaturated carboxylic acid monomer is dropped into an aqueous medium in which a line contrast agent powder and / or a filler powder are dispersed, and radically polymerized. The polymerization conditions are not particularly limited, but generally it is appropriate to carry out the polymerization at 50 to 100 ° C. under normal pressure. The ratio between the X-ray contrast agent powder and / or the filler powder and the monomer is not particularly limited, except for physical and chemical conditions that substantially hinder polymerization. Considering the stability of the aqueous suspension of the linear contrast agent complex or the polymer-filler complex and the original function as a curing agent, the weight ratio is (0.1 to 1).
0): (99.9 to 90) is appropriate. However, since the reactivity differs depending on the type of the dental cement powder or the monomer, a suitable ratio can be appropriately selected.

【0019】このようにして得られた本発明のセメント
硬化剤は、前記水系媒体中で重合させて得られた重合体
−X線造影剤複合体、もしくは重合体−充填剤複合体の
水性懸濁液のまま、もしくは該懸濁液を水系媒体で濃度
調整したものを凍結乾燥等の手段により一旦重合体−X
線造影剤複合体、もしくは重合体−充填剤複合体の乾燥
粉末にし、使用時、再び水性媒体に分散、懸濁させて使
用することも可能である。ただし、未反応の残存モノマ
ー等を除去、精製することが望しく、例えばその手段と
して凍結乾燥法により重合体−X線造影剤複合体、もし
くは重合体−充填剤複合体の乾燥粉末を一旦造り、これ
を水系媒体に再懸濁分散させ、安全性の高い、安定性の
よいセメント硬化剤とするのが好適である。なお、セメ
ント硬化剤の水性懸濁液の固形分濃度は、前記モノマー
の種類やX線造影剤及び/又は、充填剤成分の種類、粒
度等により任意に決定されるが、一般的には30〜70
重量%が適当である。
The cement hardener of the present invention thus obtained is prepared by polymerizing the cement-hardening agent of the present invention in the above-mentioned aqueous medium to obtain an aqueous suspension of the polymer-X-ray contrast agent composite or the polymer-filler composite. The suspension, or the suspension whose concentration has been adjusted with an aqueous medium, is temporarily subjected to polymer-X by means such as freeze-drying.
It is also possible to prepare a dry powder of a linear contrast agent composite or a polymer-filler composite, and to disperse and suspend it again in an aqueous medium before use. However, it is desirable to remove and purify unreacted residual monomers and the like. For example, a dry powder of a polymer-X-ray contrast agent complex or a polymer-filler complex is once prepared by a freeze-drying method as a means thereof. This is preferably re-suspended and dispersed in an aqueous medium to provide a highly safe and stable cement hardener. The solid concentration of the aqueous suspension of the cement hardening agent is arbitrarily determined depending on the type of the monomer, the type of the X-ray contrast agent and / or the type and the particle size of the filler component. ~ 70
% By weight is appropriate.

【0020】本発明のセメント硬化剤の水性懸濁液は、
使用直前に歯科用セメント粉末、さらに必要に応じX線
造影剤粉末、充填剤粉末からなる粉末成分と混合、練和
することにより歯科セメント組成物が調製される。
The aqueous suspension of the cement setting agent of the present invention comprises
Immediately before use, a dental cement composition is prepared by mixing and kneading with a dental cement powder and, if necessary, a powder component comprising an X-ray contrast agent powder and a filler powder.

【0021】なお歯科用セメント粉末としてはリン酸亜
鉛セメント、酸化亜鉛を主成分とするポリカルボキシレ
ートセメント、燐酸カルシウムを主成分とする燐酸カル
シウムセメント、フルオロアルミノシリケートガラスや
アルミノフルオロケイ酸アルカリ土類金属塩ガラス等の
グラスアイオノマーセメント等が代表的なものとして挙
げられるが、これらに限定されるものではない。
The dental cement powder includes zinc phosphate cement, polycarboxylate cement containing zinc oxide as a main component, calcium phosphate cement containing calcium phosphate as a main component, fluoroaluminosilicate glass and alkaline earth aluminofluorosilicate. Representative examples include glass ionomer cements such as metal salt glass, but are not limited thereto.

【0022】また歯科用セメント粉末は、粉末成分中8
5〜100重量%とするのが得られるセメント硬化物の
物理的強度の観点から望ましい。
The dental cement powder contains 8% of the powder component.
It is desirable from 5% to 100% by weight from the viewpoint of the physical strength of the cured cement product obtained.

【0023】以上、説明したような本発明の重合体−X
線造影剤複合体、もしくは重合体−充填剤複合体からな
る硬化剤の水性懸濁液が粉末成分と練和性がよくなる理
由は定かではないが、次のような理由によるものと推定
される。
The polymer-X of the present invention as described above
The reason that the aqueous suspension of the hardener comprising the linear contrast agent complex or the polymer-filler complex improves the kneadability with the powder component is not clear, but is presumed to be due to the following reasons. .

【0024】硬化剤となる複合体を構成する、X線造影
剤粉末及び/又は、充填剤粉末表面をモノマーと接触さ
せ、X線造影剤粉末及び/又は、充填剤粉末表面をなじ
ませて、よくぬらし、その状態を保ちながらモノマーを
重合させると、X線造影剤粉末及び/又は、充填剤粉末
本来の一次粒子の会合体よりなる二次的粒塊は、ばらば
らにほぐれ、最終的には水系媒体と親和性のよい高分子
鎖をもつ重合体で包まれた重合体−X線造影剤複合体、
もしくは重合体−充填剤複合体の細粒となり、良好な分
散系が完成するものと考えられる。
The surface of the X-ray contrast agent powder and / or the filler powder constituting the composite as a curing agent is brought into contact with a monomer, and the surface of the X-ray contrast agent powder and / or the filler powder is blended. When the monomer is polymerized while keeping the state well wet, the X-ray contrast agent powder and / or the secondary agglomerate composed of the aggregates of the primary particles of the filler powder are loosened apart, and finally A polymer-X-ray contrast agent complex wrapped with a polymer having a polymer chain having a good affinity for an aqueous medium,
Alternatively, it is considered that fine particles of the polymer-filler composite are formed, and a good dispersion system is completed.

【0025】このように重合体の生成とともにX線造影
剤、もしくは充填剤粒子の細粒化、分散化が起こること
は、触媒化学において重合反応進行とともに重合触媒が
破砕、粉化されていくことが確かめられている事実から
も容易に推定される。
As described above, the generation of the polymer and the reduction and dispersion of the X-ray contrast agent or the filler particles are caused by the fact that the polymerization catalyst is crushed and powdered with the progress of the polymerization reaction in catalytic chemistry. Can be easily inferred from the facts that have been confirmed.

【0026】このようにして得られた本発明の重合体−
X線造影剤、もしくは重合体−充填剤複合体からなる硬
化剤の水性懸濁液に乾燥粉末成分を接触させると粉末成
分は容易に水性懸濁液の系内にとり込まれ、すみやかに
相互にぬれ、なじみがよくなり、かつ分散安定性もよく
なり、その結果流動性がよくなり、練和の際の抵抗が小
さくなり、操作性、練和性が良好になるものと考えられ
る。
The polymer of the present invention thus obtained
When the dry powder component is brought into contact with an aqueous suspension of an X-ray contrast agent or a curing agent composed of a polymer-filler complex, the powder components are easily incorporated into the aqueous suspension system, and quickly interact with each other. It is considered that the wettability and conformability are improved, and the dispersion stability is improved. As a result, the fluidity is improved, the resistance during kneading is reduced, and the operability and kneadability are improved.

【0027】なお、このような現象は、ある種のコロイ
ドやエマルジョン系において一旦その安定系が生成する
と新たな媒質の取り込みが容易になり、急速に分散安定
化へ移行する過程が確かめられている事実とよく符号し
ている。また、このような効果は、いくつかのデータに
よっても裏付けられる。
It has been confirmed that once such a stable system is formed in a certain kind of colloid or emulsion system, it is easy to take in a new medium and the process rapidly shifts to dispersion stabilization. Signs well with facts. Such effects are also supported by some data.

【0028】例えば、同一粒度分布を有する乾燥粉末成
分に、同一濃度の硬化剤、即ち従来のポリアクリル酸重
合体水溶液と、本発明の重合体−X線造影剤複合体、も
しくは重合体−充填剤複合体水性懸濁液とをそれぞれ混
合し、練和初期における練和物をそれぞれ同量、ガラス
板に垂らすと本発明の硬化剤である重合体−X線造影剤
複合体、もしくは重合体−充填剤複合体水性懸濁液を使
用した方が膜厚がうすく広がった。このことからも短時
間の練和で粉末成分がよくほぐれ、均一な分散状態とな
っていることが証明される。
For example, a dry powder component having the same particle size distribution is mixed with a curing agent having the same concentration, that is, a conventional polyacrylic acid polymer aqueous solution, and a polymer-X-ray contrast agent complex or polymer-filled material of the present invention. Each of the aqueous composite suspensions was mixed with an aqueous suspension, and the same amount of the kneaded material in the initial stage of kneading was dropped on a glass plate to obtain a polymer-X-ray contrast agent composite or a polymer which is a curing agent of the present invention -The use of the aqueous filler complex suspension resulted in a thinner film thickness. This also proves that the powder components are easily loosened and kneaded in a short time to form a uniform dispersion state.

【0029】本発明の重合体−X線造影剤複合体、もし
くは重合体−充填剤複合体からなる硬化剤の水性懸濁液
(L)は使用直前に粉末成分(P)と、一般的には
(P)/(L)(重量比)が1〜3となる割合で混合、
練和されて使用に供されるが、その際、初期硬化速度、
硬度、接着性、破砕抗力、崩壊率などを改善するために
例えばエチレンジアミンテトラ酢酸、ジヒドロキシ酒石
酸、サリチル酸、2,4−及び2,6−ジヒドロキシ安
息香酸、クエン酸、ニトリロトリ酢酸、酒石酸、その他
の分子内に2個以上のカルボキシル基を有する化合物、
β−ジケトン、ポリグリコール等のキレート化剤を全体
に対し数重量%添加するのが好ましい。
The aqueous suspension (L) of the curing agent comprising the polymer-X-ray contrast agent complex or the polymer-filler complex of the present invention is mixed with the powder component (P) immediately before use, and generally, Is mixed at a ratio of (P) / (L) (weight ratio) of 1 to 3,
It is kneaded and used for use, at that time, the initial curing speed,
For example, ethylenediaminetetraacetic acid, dihydroxytartaric acid, salicylic acid, 2,4- and 2,6-dihydroxybenzoic acid, citric acid, nitrilotriacetic acid, tartaric acid, and other molecules to improve hardness, adhesion, crushing resistance, disintegration rate, etc. A compound having two or more carboxyl groups in the
It is preferable to add a chelating agent such as β-diketone or polyglycol to the whole by several weight%.

【0030】[0030]

【発明の効果】本発明の重合体−X線造影剤複合体、ま
たは重合体−充填剤複合体からなる歯科用セメント硬化
剤は従来の硬化剤に比較し、乾燥セメント粉末からなる
粉末成分と混合する際に、その操作性、練和性に優れ、
それ故熟練を左程必要としないで短時間で十分練和出来
る。また、破砕抗力等の物理的強度に優れたセメント硬
化物が得られ、かつ最終性能にバラツキのないものが得
られるといった効果を有し、従来にない画期的な硬化剤
といえる。
The dental cement hardener comprising the polymer-X-ray contrast agent composite or the polymer-filler composite of the present invention is different from the conventional hardeners in that the powder component consisting of dry cement powder and When mixing, its operability and kneadability are excellent,
Therefore, it can be sufficiently kneaded in a short time without requiring much skill. In addition, it has the effect of obtaining a hardened cement material having excellent physical strength such as crushing resistance and the like, and having no variation in final performance.

【0031】[0031]

【実施例】以下、本発明を実施例により、更に詳細に説
明する。なお、実施例中「部」、「%」は重量基準で示
す。
The present invention will be described in more detail with reference to the following examples. In the examples, "parts" and "%" are shown on a weight basis.

【0032】<グラスアイオノマーセメント粉末の調製
方法>Al2O3 100部、SiO2175部、Na3AlF6 30
部、CaF2207部、AlF332部、AlPO4 60部を粉砕、
混合し、1150℃にて焼成し、ついで粉砕して400
メッシュ篩を通過させてグラスアイオノマーセメント粉
末を得た。
[0032] <Preparation method of glass ionomer cement powder> Al 2 O 3 100 parts, SiO 2 175 parts, Na 3 AlF 6 30
Parts, 207 parts of CaF 2 , 32 parts of AlF 3 , and 60 parts of AlPO 4
Mix, bake at 1150 ° C, then pulverize 400
The mixture was passed through a mesh sieve to obtain a glass ionomer cement powder.

【0033】実施例1 水64.00部、エタノール8.00部、イタコン酸4.00
部、硫酸バリウム粉末0.10部を入れたフラスコをセッ
トした合成反応装置を80℃に保ち、重合開始剤として
過硫酸アンモニウム(APS)0.70部を水4.00部と
混合したものを加えた後、アクリル酸16.00部を滴下
ロートにて2時間かけて均一に滴下した。滴下終了後追
加触媒としてAPS0.30部を水4.00部と混合したも
のを加え、更に90分間80℃にてエージングを行っ
た。次に、未反応モノマーを除去するために、これを凍
結真空乾燥し、得られた粉末49.50部と水45.0部と
を混合し、硬化剤水性懸濁液を製造した。
Example 1 64.0 parts of water, 8.00 parts of ethanol, 4.00 of itaconic acid
Of a flask containing 0.10 parts of barium sulfate powder and 0.10 parts of barium sulfate powder, the mixture was kept at 80 ° C., and a mixture of 0.70 parts of ammonium persulfate (APS) with 4.00 parts of water as a polymerization initiator was added. After that, 16.00 parts of acrylic acid was uniformly dropped by a dropping funnel over 2 hours. After completion of the dropwise addition, a mixture of 0.30 parts of APS and 4.00 parts of water was added as an additional catalyst, and aging was further performed at 80 ° C. for 90 minutes. Next, in order to remove the unreacted monomer, it was freeze-dried and dried, and 49.50 parts of the obtained powder and 45.0 parts of water were mixed to produce an aqueous suspension of a curing agent.

【0034】実施例2 実施例1において、硫酸バリウム粉末を1.00部とする
以外は実施例1と同様にして硬化剤水性懸濁液を製造し
た。
Example 2 An aqueous suspension of a curing agent was prepared in the same manner as in Example 1 except that 1.00 part of barium sulfate powder was used.

【0035】実施例3 実施例1において、硫酸バリウム粉末を次炭酸ビスマス
粉末0.10部に代える以外は実施例1と同様にして硬化
剤水性懸濁液を製造した。
Example 3 An aqueous hardener suspension was prepared in the same manner as in Example 1, except that the barium sulfate powder was replaced by 0.10 parts of bismuth subcarbonate powder.

【0036】実施例4 実施例3において、次炭酸ビスマス粉末0.10部を1.0
0部とする以外は実施例3と同様にして硬化剤水性懸濁
液を製造した。
Example 4 In Example 3, 0.10 part of bismuth subcarbonate powder was added to 1.0 part.
An aqueous hardener suspension was prepared in the same manner as in Example 3 except that the amount was 0 part.

【0037】実施例5 実施例1において、硫酸バリウム粉末を酸化マグネシウ
ム粉末0.10部に代える以外は実施例1と同様にして硬
化剤水性懸濁液を製造した。
Example 5 An aqueous suspension of a curing agent was prepared in the same manner as in Example 1, except that the barium sulfate powder was replaced by 0.10 parts of magnesium oxide powder.

【0038】実施例6 実施例5において、酸化マグネシウム粉末0.10部を1.
00部とする以外は実施例5と同様にして硬化剤水性懸
濁液を製造した。
Example 6 In Example 5, 0.10 parts of magnesium oxide powder was added to 1.
A curing agent aqueous suspension was produced in the same manner as in Example 5 except that the amount was changed to 00 parts.

【0039】実施例7 実施例1において、硫酸バリウム粉末を水酸化カルシウ
ム粉末0.10部に代える以外は実施例1と同様にして硬
化剤水性懸濁液を製造した。
Example 7 An aqueous suspension of a curing agent was produced in the same manner as in Example 1 except that the barium sulfate powder was replaced by 0.10 parts of calcium hydroxide powder.

【0040】実施例8 実施例7において、水酸化カルシウム粉末0.10部を1.
00部とする以外は実施例7と同様にして硬化剤水性懸
濁液を製造した。
Example 8 In Example 7, 0.10 part of calcium hydroxide powder was added to 1.
A curing agent aqueous suspension was produced in the same manner as in Example 7 except that the amount was changed to 00 parts.

【0041】実施例9 実施例1において、イタコン酸をマレイン酸とする以外
は実施例1と同様にして硬化剤水性懸濁液を製造した。実施例10 実施例1において、イタコン酸4.00部の代わりにイ
タコン酸2.00部とアコニット酸2.00部の混合物
を使用する以外は実施例1と同様にして硬化剤水性懸濁
液を製造した。 実施例11 実施例1において、アクリル酸16.00部の代わりに
アクリル酸14.00部とメチルメタクリレート2.0
0部の混合物を使用する以外は実施例1と同様にして硬
化剤水性懸濁液を製造した。 実施例12 実施例1において、アクリル酸16.00部の代わりに
アクリル酸14.00部とスチレン2.00部の混合物
を使用する以外は実施例1と同様にして硬化剤水性懸濁
液を製造した。 実施例13 実施例1において、アクリル酸16.00部をアクリル
酸20.00部とする以外は実施例1と同様にして硬化
剤水性懸濁液を製造した。
Example 9 An aqueous suspension of a curing agent was produced in the same manner as in Example 1 except that maleic acid was used instead of itaconic acid. Example 10 The procedure of Example 1 was repeated, except that 4.00 parts of itaconic acid was replaced with a
A mixture of 2.00 parts of taconic acid and 2.00 parts of aconitic acid
Aqueous suspension of a curing agent in the same manner as in Example 1 except that
A liquid was produced. Example 11 In Example 1, instead of 16.00 parts of acrylic acid,
14.00 parts of acrylic acid and 2.0 of methyl methacrylate
Hardening was performed in the same manner as in Example 1 except that 0 parts of the mixture was used.
An aqueous suspension of the agent was prepared. Example 12 In Example 1, instead of 16.00 parts of acrylic acid,
A mixture of 14.00 parts of acrylic acid and 2.00 parts of styrene
Aqueous suspension of a curing agent in the same manner as in Example 1 except that
A liquid was produced. Example 13 In Example 1, 16.00 parts of acrylic acid was replaced with acrylic acid.
Cured in the same manner as in Example 1 except that the acid is 20.00 parts.
Aqueous suspensions were prepared.

【0042】 比較例1 実施例1において、硫酸バリウム粉末を添加しない以外
は実施例1と同様にして硬化剤水性懸濁液を製造した。
Comparative Example 1 An aqueous suspension of a curing agent was produced in the same manner as in Example 1 except that barium sulfate powder was not added.

【0043】このようにして得られた各硬化剤水溶液9.
5部と酒石酸0.5部とからなる液剤(L)と前記グラス
アイオノマーセメント粉末18.0部からなる粉剤(P)
とを30秒間練和し、その24時間後の破砕抗力を歯科
用セメントJIS T 6602記載の方法に準拠して測定した。
また、練和性試験は以下のようにして決定した。 練和性試験:前記粉剤(P)0.30部と液剤(L)0.2
0部を練和紙上にとり、15秒間練和を行ない練和した
セメント組成物をガラス板上に置き、これに重さ20g
のガラス板を載せ、その上に100gのおもりを載せ、
10分経過したときに広がった試料の最大径と最小径の
平均値を求め、これを練和性(流動性)の尺度とした。
平均値が大きいほど、練和性の良いことを示す。
Each hardener aqueous solution thus obtained 9.
Liquid (L) consisting of 5 parts and 0.5 part of tartaric acid, and powder (P) consisting of 18.0 parts of the above glass ionomer cement powder
Were kneaded for 30 seconds, and the crushing resistance 24 hours later was measured according to the method described in JIS T 6602 for dental cement.
The kneadability test was determined as follows. Kneadability test: 0.30 parts of powder (P) and 0.2 of liquid (L)
Take 0 part on kneaded paper, knead for 15 seconds, place the kneaded cement composition on a glass plate, weigh 20 g
Put a 100g weight on the glass plate,
The average value of the maximum diameter and the minimum diameter of the sample that spread when 10 minutes had elapsed was determined, and this was used as a measure of kneadability (fluidity).
The larger the average value, the better the kneadability.

【0044】結果を以下の第1表に示す。The results are shown in Table 1 below.

【0045】[0045]

【表1】 第1表より明らかなように、本発明の硬化剤を使用した
各実施例の歯科セメント組成物は、従来の硬化剤を使用
した比較例1のものと比べて、いずれも破砕抗力及び練
和性が優れていた。
[Table 1] As is clear from Table 1, all of the dental cement compositions of the examples using the hardener of the present invention had a higher crushing resistance and kneading strength than those of Comparative Example 1 using the conventional hardener. The character was excellent.

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 水系媒体中において、X線造影剤粉末及
び/又は充填剤粉末存在下で、不飽和カルボン酸モノマ
ーまたは該モノマーと他の共重合性不飽和モノマーとの
混合モノマーを重合させることによって得られる重合体
−X線造影剤複合体及び/又は重合体−充填剤複合体か
らなる歯科用セメント硬化剤。
1. Polymerizing an unsaturated carboxylic acid monomer or a mixed monomer of said monomer and another copolymerizable unsaturated monomer in an aqueous medium in the presence of an X-ray contrast agent powder and / or a filler powder. A dental cement hardener comprising a polymer-X-ray contrast agent composite and / or a polymer-filler composite obtained by the method described above.
JP2401034A 1990-12-10 1990-12-10 Dental cement hardener Expired - Lifetime JP2883741B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2401034A JP2883741B2 (en) 1990-12-10 1990-12-10 Dental cement hardener

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2401034A JP2883741B2 (en) 1990-12-10 1990-12-10 Dental cement hardener

Publications (2)

Publication Number Publication Date
JPH0624927A JPH0624927A (en) 1994-02-01
JP2883741B2 true JP2883741B2 (en) 1999-04-19

Family

ID=18510896

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2401034A Expired - Lifetime JP2883741B2 (en) 1990-12-10 1990-12-10 Dental cement hardener

Country Status (1)

Country Link
JP (1) JP2883741B2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001192853A (en) * 1999-10-29 2001-07-17 Matsumoto Shika Univ Method for forming oxide film on metal member for bonding and method for bonding metal member
EP1307173B1 (en) * 2000-08-07 2008-10-15 S & C Polymer Silicon- und Composite-Spezialitäten GmbH Adhesive fluoride varnish
DE10043151A1 (en) * 2000-08-31 2002-03-28 Peter Steinruecke Bone cement with antimicrobial effectiveness
JP2006290763A (en) * 2005-04-07 2006-10-26 Shiyoufuu:Kk Low-irritant medical or dental material and composition containing the same
DE102011114576A1 (en) * 2011-09-30 2013-04-04 Thermo Electron (Karlsruhe) Gmbh extruder
GB201317299D0 (en) 2013-09-30 2013-11-13 Lucite Int Uk Ltd A hardenable multi-part acrylic composition

Also Published As

Publication number Publication date
JPH0624927A (en) 1994-02-01

Similar Documents

Publication Publication Date Title
JP4460285B2 (en) Glass ionomer cement
KR100245578B1 (en) Water-based medical and dental cement
US6281271B1 (en) Radically polymerizable dental material
US5130347A (en) Photocurable ionomer cement systems
US5063257A (en) Dental glass ionomer cement compositions
US4389497A (en) Use of agglomerates of silicic acid as fillers in dental materials
JPH11228327A (en) Pasty glass ionomer cement composition for dentistry
JP4629339B2 (en) Compositions, kits and methods containing polymerizable reducing agents
AU720490B2 (en) Improvements in or relating to polymerisable cement compositions
JP2003183112A (en) Pasty glass ionomer cement composition for dental use
JP6161733B2 (en) Dental glass ionomer cement filler and method for producing the same
JP2883741B2 (en) Dental cement hardener
JP2813906B2 (en) Dental cement hardener
JP4798680B2 (en) Dental curable composition
JPH0948702A (en) Dental cement composition
WO2021131476A1 (en) Curable composition for dentistry
JP2003095837A (en) Glass powder for glass ionomer cement
JP4926440B2 (en) Dental glass ionomer cement solution
JP3450059B2 (en) Glass powder for dental cement
JPS6337083B2 (en)
JP7588774B2 (en) Method for producing dental hardenable composition
JP7674030B2 (en) Dental Composition
JPH0322842B2 (en)
JPH03130210A (en) Dental cement hardening liquid
JPH0667815B2 (en) Dental cement hardening liquid

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19990111